ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.508,67
1,09%
S&P 500
5.127,79
1,26%
US Dollar vs BRL
5,0724
0,00%
Bitcoin
63.896,22
1,60%
Brent Oil
82,765
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Canadá
  5. TSX
  6. Resverlogix Corp (RVX)

  7. Resverlogix Corp (RVX) Notícias

RVX

Resverlogix (RVX)

Resverlogix Corp
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:TSX:RVX
DataHoraFonteTítuloCódigoCompanhia
03/11/202114:45InvestorsHub NewsWireRESVERLOGIX ENTERS INTO A COOPERATION AGREEMENT WITH THE SUPREME COUNCIL OF THE ARAB-AFRICAN ECONOMY TO SUPPORT THE DEVELOPMENT OF APABETALONE FOR COVID-19 PATIENTSTSX:RVXResverlogix Corp
26/09/201910:00PR Newswire (Canada)Toronto Stock Exchange Introduces the TSX30TSX:RVXResverlogix Corp
26/09/201910:00PR Newswire (Canada)La Bourse de Toronto lance le palmarès TSX 30TSX:RVXResverlogix Corp
15/05/201909:59PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - RVXTSX:RVXResverlogix Corp
15/05/201909:58PR Newswire (Canada)IIROC Trade Resumption - RVXTSX:RVXResverlogix Corp
15/05/201909:26PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - RVXTSX:RVXResverlogix Corp
15/05/201909:24PR Newswire (Canada)IIROC Trading Halt - RVXTSX:RVXResverlogix Corp
13/09/201719:41PR Newswire (US)Resverlogix Announces Filing of Quarterly Financial Statements and Management's Discussion & AnalysisTSX:RVXResverlogix Corp
05/09/201708:00PR Newswire (Canada)Resverlogix Closes Extension of Maturity Date of Loan and Announces Private PlacementTSX:RVXResverlogix Corp
29/08/201715:01PR Newswire (US)Successful CANTOS Inflammation Trial Supports Rationale for Resverlogix' Ongoing BETonMACE TrialTSX:RVXResverlogix Corp
28/08/201708:00PR Newswire (US)Resverlogix Announces Extension of Maturity Date of Loan and Expression of Interest Regarding Strategic TransactionTSX:RVXResverlogix Corp
25/07/201719:30PR Newswire (US)Resverlogix Files 2017 Year-End Disclosure Documents and Announces Plans to Host a Symposium at the European Society of Cardi...TSX:RVXResverlogix Corp
25/07/201710:00PR Newswire (US)Resverlogix Receives Approval Pathway from the FDA as to the Inclusion of USA Patients in the Phase 3 BETonMACE TrialTSX:RVXResverlogix Corp
10/07/201708:00PR Newswire (US)Resverlogix Randomizes First Patient in Taiwan/China Portion of the Phase 3 BETonMACE Clinical TrialTSX:RVXResverlogix Corp
28/06/201708:00PR Newswire (Canada)Resverlogix Announces Fourth Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of ApabetaloneTSX:RVXResverlogix Corp
21/06/201710:27PR Newswire (Canada)Resverlogix Comments on TSX Trader NotesTSX:RVXResverlogix Corp
20/06/201711:04PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - RVX.WTTSX:RVXResverlogix Corp
20/06/201710:59PR Newswire (Canada)IIROC Trade Resumption - RVX.WTTSX:RVXResverlogix Corp
20/06/201710:34PR Newswire (Canada)Resverlogix Closes $10 Million of Equity SubscriptionsTSX:RVXResverlogix Corp
20/06/201709:17PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - RVX.WTTSX:RVXResverlogix Corp
20/06/201709:16PR Newswire (Canada)IIROC Trading Halt - RVX.WTTSX:RVXResverlogix Corp
09/06/201710:50PR Newswire (Canada)Resverlogix to Raise Up To $10 MillionTSX:RVXResverlogix Corp
08/06/201717:01PR Newswire (Canada)Resverlogix Announces Overnight Marketed Equity OfferingTSX:RVXResverlogix Corp
05/06/201707:55PR Newswire (US)Resverlogix Announces Lead Drug Apabetalone Publication and Presentation at BIO International 2017TSX:RVXResverlogix Corp
31/05/201708:00PR Newswire (US)Resverlogix to Host Epigenetics Focused Symposium at The ERA-EDTA Congress in Madrid, SpainTSX:RVXResverlogix Corp
31/05/201708:00PR Newswire (US)Resverlogix To Host Epigenetics Focused Symposium At The ERA-EDTA Congress in Madrid, SpainTSX:RVXResverlogix Corp
30/05/201708:00PR Newswire (US)Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound ApabetaloneTSX:RVXResverlogix Corp
30/05/201708:00PR Newswire (US)Resverlogix Receives Approval From Health Canada to Proceed With Fabry Disease Clinical Trial With Lead Compound ApabetaloneTSX:RVXResverlogix Corp
23/05/201708:00PR Newswire (Canada)Recent Publication and Patent Application Referencing Apabetalone Support its Continued Development and SuccessTSX:RVXResverlogix Corp
15/05/201711:28PR Newswire (US)Resverlogix Receives Approval From the FDA Cardiovascular and Renal Division to Proceed With a Requested Apabetalone Clinical...TSX:RVXResverlogix Corp
 Apresentando as notícias mais relevantes sobre:TSX:RVX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
HOOT4
HOTEIS OTHON PN
BOV
PRIO3
PETRORIO ON
BOV
TELB4
TELEBRAS PN
BOV
ZAMP3
Zamp ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados